Vulva (including Skin of Vulva) (excluding Malignant Melanoma, Merkel Cell Carcinoma, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease, and Other Lymphomas)
Primary Site | Histology | Staging Type |
---|---|---|
C510-C512, C518-C519 | 8000-8246, 8248-8576, 8940-8950, 8980-8981 | TNM 7 and Summary Stage |
C510-C512, C518-C519 | 8577-8713, 8800-8939, 8951-8979, 8982-9136, 9141-9582 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C510 Labium majus C511 Labium minus C512 Clitoris C518 Overlapping lesion of vulva C519 Vulva, NOS **Note 1:** This schema is based on the UICC chapter *Vulva,* pages 197-201. * This classification applies to primary carcinomas of the vulva. A carcinoma of the vulva that has extended to the vagina is classified as carcinoma of the vulva **Note 2:** Involvement of the vulva and perineum should be assigned to vulva as the primary site in the absence of a statement that the tumor extended from the perineum to the vulva. This schema only includes C510-C519 (vulva) and does not include primaries of the perineum. Basal and squamous cell carcinomas of the skin of the vulva are coded to C519 and are reportable; basal and squamous carcinomas of the skin of the perineum would be coded to C445 and would not be reportable. **Note 3:** The FIGO stages are based on surgical staging. (TNM stages are based on clinical and/or pathologic classification). **Note 4:** TNM values correspond to the stages accepted by the Federation Internationale de Gynecologic et d'Obstetrique (FIGO). Note that FIGO uses a single stage value which corresponds to different groupings of T, N, and M values. **Note 5:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Vulva* chapter on page 198 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=198).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes |
NAACCR #940
tnmClinT |
None | |
Clinical N | <BLANK> | Yes |
NAACCR #950
tnmClinN |
None | |
Clinical M | <BLANK> | Yes |
NAACCR #960
tnmClinM |
None | |
TNM Clin Stage Group | 99 | Yes |
NAACCR #970
tnmClinStageGroup |
None | |
Pathologic T | <BLANK> | Yes |
NAACCR #880
tnmPathT |
None | |
Pathologic N | <BLANK> | Yes |
NAACCR #890
tnmPathN |
None | |
Pathologic M | <BLANK> | Yes |
NAACCR #900
tnmPathM |
None | |
TNM Path Stage Group | 99 | Yes |
NAACCR #910
tnmPathStageGroup |
None | |
SSF10: FIGO Stage | 988 | No |
NAACCR #2864
csSiteSpecificFactor10 |
CCCR/Canada COC |
None |
SSF11: Regional Lymph Node - Laterality | 999 | No |
NAACCR #2865
csSiteSpecificFactor11 |
CCCR/Canada SEER |
None |
SSF12: Pelvic Nodal Status | 988 | No |
NAACCR #2866
csSiteSpecificFactor12 |
None | None |
SSF13: Assessment Method of Pelvic Nodal Status | 988 | No |
NAACCR #2867
csSiteSpecificFactor13 |
None | None |
SSF14: Femoral Inguinal Nodal Status | 988 | No |
NAACCR #2868
csSiteSpecificFactor14 |
None | None |
SSF15: Assessment Method of Femoral Inguinal Nodal Status | 988 | No |
NAACCR #2869
csSiteSpecificFactor15 |
None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes |
NAACCR #1380
rxSummSurgRadSeq |
None | |
Regional Nodes Positive | <BLANK> | Yes |
NAACCR #820
regionalNodesPositive |
None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
derivedSeerClinStgGrp |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
derivedSeerPathStgGrp |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
derivedSeerCmbStgGrp |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
derivedSeerCombinedT |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
derivedSeerCombinedN |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
derivedSeerCombinedM |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
derivedSeerCmbTSrc |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
derivedSeerCmbNSrc |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
derivedSeerCmbMSrc |
None |